MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Gilenya 0.5mg capsules (Novartis Pharmaceuticals UK Ltd).

Stability Notes

No special precautions for storage. Monthly preparation. Complex administration regime makes it unsuitable for MCA.

Provenance

This compatibility recommendation is derived from Bonviva 150mg tablets (Atnahs Pharma UK Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

Store in non-metallic airtight containers, protect from light. Store in a dry place.

Provenance

This compatibility recommendation is derived from Ascorbic acid 500mg tablets (Ennogen Pharma Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Stability Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from all strengths of Lyrica capsules (Viatris UK Healthcare Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.